Turing Medical Technologies, Inc.
4 software found

Turing Medical Technologies, Inc. software

Turing Medical - Personalized Adaptive Cortical Electro-Stimulation (PACE) for Neuromodulation

PACE represents a transformative advance in neuromodulation therapies by employing Personalized Adaptive Cortical Electro-Stimulation. This innovative approach is designed to deliver targeted therapies through the Bullsai platform, renowned for its precise mapping capabilities. PACE is currently under clinical development to treat conditions such as treatment-resistant depression, with further applications for a variety of neuropsychiatric and pain disorders anticipated. The technology builds on the FDA 510(k) cleared Bullsai platform which constructs patient-specific brain maps, optimizing neuromodulation targeting through adaptive algorithms that adjust stimuli in real-time. This closed-loop system enhances efficacy and safety, tailoring therapy to individual brain circuits. PACE stands out with its minimally invasive delivery method, offering a durable neurotherapy solution that aligns FDA-cleared mapping technology with novel therapeutic methodologies to advance personalized neural treatments.

Turing Medical - Model FIRMM - MRI Motion Metrics Software

FIRMM software is specifically engineered to deliver precise real-time motion metrics derived from brain MRI data. By integrating seamlessly into existing MRI workflows, it aids technologists, researchers, and physicians in achieving higher data accuracy and improved diagnostic capabilities. The software is recognized for its ability to save significant time and reduce costs, with estimates indicating annual savings exceeding $115,000 per scanner and a reduction in the need for repeat scans by approximately 25%. It provides continuous monitoring of motion metrics and data quality in real-time, facilitating immediate adjustments to scanning protocols. FIRMM stands out as it is FDA 510(k) cleared, underscoring its safety and effectiveness for clinical use. This software not only optimizes workflow efficiency but also enhances the precision of neuroimaging studies by offering clear visualizations and diagnostics.

Turing Medical - Bullsai Neuromodulation Targeting Platform

The Bullsai platform from Turing Medical offers cutting-edge solutions for precision targeting in neuromodulation therapies. This system leverages automated workflows to enhance the accuracy and efficiency of advanced imaging, essential for patient-specific targeting. By freeing clinicians to focus on patient care, Bullsai ensures more personalized treatment approaches. The platform includes several key features: Bullsai Enhance provides high-quality input with real-time feedback and data quality control, while Bullsai Identify employs AI/ML to pinpoint functional targets with advanced visualization. Bullsai Confirm delivers visual confirmation for electrode placements. These FDA 510(k) cleared tools are integral in mapping structural and functional brain connections, crucial for therapies in neuropsychiatric disorders. Turing Medical's innovations in neuromodulation aim to balance activity across affected brain networks, presenting a new frontier in personalized medical interventions.

Turing Medical - Model FIRMM-pix - MRI Motion Management System

The FIRMM-pix system is designed to enhance MRI imaging accuracy by addressing the challenges of motion-induced image degradation, a common obstacle in brain MRIs. By integrating biofeedback and gamification, FIRMM-pix offers an innovative approach to train patients, including children, to minimize movements during scans. This method prevents the need for sedation or repeat scans, showcasing a more efficient and cost-effective alternative. Featuring tools like 'Puppy Dreams', a premier game, it guides patients with real-time feedback and engaging content, significantly improving data quality. FIRMM-pix also includes a video player offering films for visual feedback, thus reducing movement and enhancing overall data integrity. This system is particularly valuable for neurosurgery, enabling more precise treatment planning by reducing motion artifacts. It holds FDA 510(k) clearance, affirming its safety and efficacy. The device is specifically intended for use under a physician's guidance, emphasizing its role in advanced medical settings.